Showing 1 - 14 results of 14 for search 'Kattan, M', query time: 0.03s
Refine Results
-
1
-
2
Systematic review of statistical methods used in molecular marker studies in cancer. by Vickers, A, Jang, K, Sargent, D, Lilja, H, Kattan, M
Published 2008Journal article -
3
Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis. by Erdamar, S, Yang, G, Harper, J, Lu, X, Kattan, M, Thompson, T, Wheeler, T
Published 1999Journal article -
4
Testosterone as a predictor of pathological stage in clinically localized prostate cancer. by Isom-Batz, G, Bianco, F, Kattan, M, Mulhall, J, Lilja, H, Eastham, J
Published 2005Journal article -
5
-
6
-
7
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined wit... by Haese, A, Vaisanen, V, Lilja, H, Kattan, M, Rittenhouse, H, Pettersson, K, Chan, D, Huland, H, Sokoll, L, Partin, A
Published 2005Journal article -
8
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue. by Steuber, T, Niemela, P, Haese, A, Pettersson, K, Erbersdobler, A, Felix Chun, K, Graefen, M, Kattan, M, Huland, H, Lilja, H
Published 2005Journal article -
9
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific anti... by Steuber, T, Vickers, A, Haese, A, Becker, C, Pettersson, K, Chun, F, Kattan, M, Eastham, J, Scardino, P, Huland, H, Lilja, H
Published 2006Journal article -
10
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer. by Haese, A, Graefen, M, Becker, C, Noldus, J, Katz, J, Cagiannos, I, Kattan, M, Scardino, P, Huland, E, Huland, H, Lilja, H
Published 2003Journal article -
11
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group. by Vickers, A, Cronin, A, Roobol, M, Hugosson, J, Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Ankerst, D, Bartsch, G, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Freedland, S, Moreira, D, Schröder, F, Lilja, H
Published 2010Journal article -
12
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. by Roobol, M, Schröder, F, Hugosson, J, Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Ankerst, D, Bartsch, G, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Freedland, S, Moreira, D, Vickers, A, Lilja, H, Steyerberg, E
Published 2012Journal article -
13
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. by Ankerst, D, Boeck, A, Freedland, S, Jones, J, Cronin, A, Roobol, M, Hugosson, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Moreira, D, Schröder, F, Lilja, H, Vickers, A, Thompson, I
Published 2014Journal article -
14
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group. by Ankerst, D, Boeck, A, Freedland, S, Thompson, I, Cronin, A, Roobol, M, Hugosson, J, Stephen Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Moreira, D, Schröder, F, Lilja, H, Vickers, A
Published 2012Journal article